Showing 1 - 2 results of 2 for search 'Pablo Engel', query time: 0.02s Refine Results
  1. 1
    Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope

    Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope by Pablo Menendez, Pablo Engel, Clara Bueno, Matteo Libero Baroni, Talia Velasco-Hernandez, Heleia Roca-Ho, Francisco Gutierrez-Aguera, Paolo Petazzi, Diego Sánchez-Martínez, Oscar Molina, Paola Ballerini, Narcis Fernandez-Fuentes

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Preclinical development of three novel CARs targeting CD79b for the treatment of non-Hodgkin’s lymphoma and characterization of the loss of the target antigen

    Preclinical development of three novel CARs targeting CD79b for the treatment of non-Hodgkin’s lymphoma and characterization of the loss of the target antigen by Manel Juan, Beatriz Martín-Antonio, Pablo Engel, Narcis Fernandez-Fuentes, Esperanza Esquinas, Alvaro Moreno-Sanz, Victor Sandá, Damian Stodulski-Ciesla, Jennifer Borregón, Virginia Peña-Blanque, Javier Fernández-Calles, Juana Serrano-Lopez, Pilar Llamas-Sillero, Laura Solán-Blanco

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: